v3.26.1
Property, Plant and Equipment
 12 Months Ended
Dec. 31, 2025
Property, plant and equipment [abstract]  
Property, Plant and Equipment Property, Plant and Equipment
(in millions €)
Land and
buildings
Equipment, tools
and installations
Construction in
progress and
advance
payments
Total
Acquisition and production costs
As of January 1, 2024
235.4
344.1
389.5
969.0
Additions
46.2
49.3
192.4
287.9
Disposals
(0.3)
(4.7)
—
(5.0)
Reclassifications
86.6
36.3
(122.9)
—
Currency differences
1.5
2.7
1.6
5.8
As of December 31, 2024
369.4
427.7
460.6
1,257.7
Additions
32.4
25.5
131.3
189.2
Disposals
(0.1)
(9.5)
(0.6)
(10.2)
Reclassifications
143.4
38.5
(181.9)
—
Currency differences
(8.7)
(8.3)
(15.9)
(32.9)
Additions from business combinations
50.0
17.6
85.0
152.6
As of December 31, 2025
586.4
491.5
478.5
1,556.4
(in millions €)
Land and
buildings
Equipment, tools
and installations
Construction in
progress and
advance
payments
Total
Cumulative depreciation and impairment
charges
As of January 1, 2024
36.2
175.6
—
211.8
Depreciation
12.3
38.3
4.3
54.9
Impairment
26.0
32.1
—
58.1
Disposals
(0.1)
(4.0)
—
(4.1)
Currency differences
0.4
1.0
0.3
1.7
As of December 31, 2024
74.8
243.0
4.6
322.4
Depreciation
23.8
50.3
—
74.1
Impairment
79.2
12.2
3.1
94.5
Disposals
—
(8.3)
—
(8.3)
Reversal of Impairment
—
(0.5)
—
(0.5)
Currency differences
(2.4)
(3.7)
(0.6)
(6.7)
As of December 31, 2025
175.4
293.0
7.1
475.5
(in millions €)
Land and
buildings
Equipment, tools
and installations
Construction in
progress and
advance
payments
Total
Carrying amount
As of December 31, 2024
294.6
184.7
456.0
935.3
As of December 31, 2025
411.0
198.5
471.4
1,080.9
The additions from business combinations related to the acquisition of CureVac and Biotheus (see Note 5).
During the year ended December 31, 2025, impairment losses amounting €94.5 million were recognized (as of
December 31, 2024: €58.1 million) based on the value in use. These were mainly related to impairment effects
on property, plant and equipment from pipeline prioritization outside of Europe equaling the carrying amount
(€57.8 million, recognized as other operating expenses) and to effects on property, plant and equipment from the
analysis on CGU External Product Sales JPT (€30.5 million, recognized in cost of sales). The respective
recoverable amount of this CGU of €28.3 million as of the year ended December 31, 2025 was based on value
in use and was determined at the level of the CGU.
Non-Current Assets by Region
As of December 31, 2025, non-current assets comprised €129.8 million in other intangible assets, goodwill,
property, plant and equipment, right-of-use assets and other assets of our subsidiaries incorporated in the United
States (as of December 31, 2024: €177.6 million), €464.2 million in the United Kingdom (as of December 31,
2024: €529.6 million) as well as €168.8 million in China (as of December 31, 2024: €0.6 million), respectively.
The remaining non-current assets of €2,511.5 million (as of December 31, 2024: €1,682.7 million) mainly relate
to entities incorporated in Germany.